Cite
HARVARD Citation
Achiron, A. et al. (2021). Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies. Therapeutic advances in neurological disorders. p. . [Online].